| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Departments of Medicine and Immunology, Division of Rheumatology, University of Colorado Health Sciences Center, Denver, CO 80262; and
Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, MO 63110
Human CR2 (CD21) is a B lymphocyte protein whose surface expression is restricted primarily to the mature cell stage during development. To study the transcriptional mechanisms that govern cell- and stage-restricted CR2 expression, we first performed transient transfection analysis using constructs extending from -5 kb to +75 bp (-5 kb/+75) in the CR2 promoter. The promoter was found to be broadly active, with no evidence of cell- or stage-specific reporter gene expression. However, the addition of a 2.5-kb intronic gene segment (containing a DNase I hypersensitive site) to the (-5-kb/+75) construct resulted in appropriate reporter gene expression, defined as the silencing of the (-5-kb/+75) promoter activity only in non-CR2-expressing cells. Interestingly, appropriate reporter gene expression required stable transfection of the constructs in cell lines, suggesting nuclear matrix or chromatin interactions may be important for appropriate CR2 gene expression. Importantly, transgenic mice also required the intronic silencer to generate lymphoid tissue-specific reporter gene expression. Some transgenic founder lines did not demonstrate reporter gene expression, however, indicating that additional transcriptional regulatory elements are present in other regions of the CR2 gene. In summary, these data support the hypothesis that human CR2 expression is regulated primarily by an intronic silencer with lineage- and B cell stage-specific activity.
This article has been cited by other articles:
|
|
 |
|
  D. Liu, J.-Y. Zhu, and Z.-X. Niu Molecular Structure and Expression of Anthropic, Ovine, and Murine Forms of Complement Receptor Type 2 Clin. Vaccine Immunol., June 1, 2008; 15(6): 901 - 910. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Debnath, K. M. Roundy, J. J. Weis, and J. H. Weis Defining In Vivo Transcription Factor Complexes of the Murine CD21 and CD23 Genes J. Immunol., June 1, 2007; 178(11): 7139 - 7150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wu, S. A. Boackle, P. Hanvivadhanakul, D. Ulgiati, J. M. Grossman, Y. Lee, N. Shen, L. J. Abraham, T. R. Mercer, E. Park, et al. Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus PNAS, March 6, 2007; 104(10): 3961 - 3966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Martin and B. K. Martin Characterization of the Murine C3a Receptor Enhancer-Promoter: Expression Control by an Activator Protein 1 Sequence and an Ets-Like Site J. Immunol., September 1, 2005; 175(5): 3123 - 3132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Maier, M. Santak, A. Mantik, K. Grabusic, E. Kremmer, W. Hammerschmidt, and B. Kempkes A Somatic Knockout of CBF1 in a Human B-Cell Line Reveals that Induction of CD21 and CCR7 by EBNA-2 Is Strictly CBF1 Dependent and that Downregulation of Immunoglobulin M Is Partially CBF1 Independent J. Virol., July 15, 2005; 79(14): 8784 - 8792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-g. Hu, H. Illges, C. Gruss, and R. Knippers Distribution of the chromatin protein DEK distinguishes active and inactive CD21/CR2 gene in pre- and mature B lymphocytes Int. Immunol., June 1, 2005; 17(6): 789 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chang, Y. Gwack, D. Kingston, J. Souvlis, X. Liang, R. E. Means, E. Cesarman, L. Hutt-Fletcher, and J. U. Jung Activation of CD21 and CD23 Gene Expression by Kaposi's Sarcoma-Associated Herpesvirus RTA J. Virol., April 15, 2005; 79(8): 4651 - 4663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Moir, A. Malaspina, O. K. Pickeral, E. T. Donoghue, J. Vasquez, N. J. Miller, S. R. Krishnan, M. A. Planta, J. F. Turney, J. S. Justement, et al. Decreased Survival of B Cells of HIV-viremic Patients Mediated by Altered Expression of Receptors of the TNF Superfamily J. Exp. Med., September 6, 2004; 200(5): 587 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cooper, E. Johannsen, S. Maruo, E. Cahir-McFarland, D. Illanes, D. Davidson, and E. Kieff EBNA3A Association with RBP-J{kappa} Down-Regulates c-myc and Epstein-Barr Virus-Transformed Lymphoblast Growth J. Virol., December 20, 2002; 77(2): 999 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tolnay, L. A. Vereshchagina, and G. C. Tsokos NF-{kappa}B Regulates the Expression of the Human Complement Receptor 2 Gene J. Immunol., December 1, 2002; 169(11): 6236 - 6243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Marchbank, L. Kulik, M. G. Gipson, B. P. Morgan, and V. M. Holers Expression of Human Complement Receptor Type 2 (CD21) in Mice During Early B Cell Development Results in a Reduction in Mature B Cells and Hypogammaglobulinemia J. Immunol., October 1, 2002; 169(7): 3526 - 3535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ulgiati, C. Pham, and V. M. Holers Functional Analysis of the Human Complement Receptor 2 (CR2/CD21) Promoter: Characterization of Basal Transcriptional Mechanisms J. Immunol., June 15, 2002; 168(12): 6279 - 6285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Zabel, W. Wheeler, J. J. Weis, and J. H. Weis Yin Yang 1, Oct1, and NFAT-4 Form Repeating, Cyclosporin-Sensitive Regulatory Modules Within the Murine CD21 Intronic Control Region J. Immunol., April 1, 2002; 168(7): 3341 - 3350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, D. C. Newton, T. L. Miller, A.-M. Teichert, M. J. Phillips, M. S. Davidoff, and P. A. Marsden An Alternative Promoter of the Human Neuronal Nitric Oxide Synthase Gene Is Expressed Specifically in Leydig Cells Am. J. Pathol., January 1, 2002; 160(1): 369 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ulgiati and V. M. Holers CR2/CD21 Proximal Promoter Activity Is Critically Dependent on a Cell Type-Specific Repressor J. Immunol., December 15, 2001; 167(12): 6912 - 6919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Himes, H. Tagoh, N. Goonetilleke, T. Sasmono, D. Oceandy, R. Clark, C. Bonifer, and D. A. Hume A highly conserved c-fms gene intronic element controls macrophage-specific and regulated expression J. Leukoc. Biol., November 1, 2001; 70(5): 812 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Vereshchagina, M. Tolnay, and G. C. Tsokos Multiple Transcription Factors Regulate the Inducible Expression of the Human Complement Receptor 2 Promoter J. Immunol., May 15, 2001; 166(10): 6156 - 6163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Makar, D. Ulgiati, J. Hagman, and V. M. Holers A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation Int. Immunol., May 1, 2001; 13(5): 657 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Schwab and H. Illges Regulation of CD21 expression by DNA methylation and histone deacetylation Int. Immunol., May 1, 2001; 13(5): 705 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Zabel, B. L. Byrne, J. J. Weis, and J. H. Weis Cell-Specific Expression of the Murine CD21 Gene Depends on Accessibility of Promoter and Intronic Elements J. Immunol., October 15, 2000; 165(8): 4437 - 4445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Marchbank, C. C. Watson, D. F. Ritsema, and V. M. Holers Expression of Human Complement Receptor 2 (CR2, CD21) in Cr2-/- Mice Restores Humoral Immune Function J. Immunol., September 1, 2000; 165(5): 2354 - 2361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Fischer, A. Mouhoub, F. Maillet, V. Fremeaux-Bacchi, C. Krief, H. Gould, S. Berrih-Aknin, and M. D. Kazatchkine Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes Int. Immunol., November 1, 1999; 11(11): 1841 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Zabel, J. J. Weis, and J. H. Weis Lymphoid Transcription of the Murine CD21 Gene Is Positively Regulated by Histone Acetylation J. Immunol., September 1, 1999; 163(5): 2697 - 2703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. ANGELIN-DUCLOS, G. CATTORETTI, D.H. CHANG, K.-I. LIN, Y. LIN, J. YU, and K. CALAME Role of B-lymphocyte-induced Maturation Protein-1 in Terminal Differentiation of B Cells and Other Cell Lineages Cold Spring Harb Symp Quant Biol, January 1, 1999; 64(0): 61 - 70. [Abstract] [PDF]
|
|
|
|
 |
|
 E. L. Virts and W. C. Raschke The Role of Intron Sequences in High Level Expression from CD45 cDNA Constructs J. Biol. Chem., June 1, 2001; 276(23): 19913 - 19920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Moir, A. Malaspina, K. M. Ogwaro, E. T. Donoghue, C. W. Hallahan, L. A. Ehler, S. Liu, J. Adelsberger, R. Lapointe, P. Hwu, et al. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals PNAS, August 28, 2001; 98(18): 10362 - 10367. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
